Long Term Effects of Eltrombopag Treatment Versus Placebo for Low-Risk Myelodysplastic Syndromes with Thrombocytopenia (EQoL-MDS): Interim Results of a Single-Blind, Randomised, Controlled, Phase II Superiority Trial
Esther Natalie Oliva1, Caterina Alati1, Valeria Santini2, et al.
1 Division of Hematology, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy
2 Hematology- MDS Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy
3 Hematology Clinic, Università Politecnica delle Marche - AOU Ospedali Riuniti, Ancona, Italy
Program: Oral and Poster Abstracts Session: 637. Myelodysplastic Syndromes – Clinical Studies: Poster II Hematology Disease Topics & Pathways: Diseases, Adult, Non-Biological, Therapies, Bleeding and clotting, MDS, Study Population, Myeloid Malignancies, Thrombocytopenias, Pharmacology Sunday, December 8, 2019, 6:00 PM-8:00 PM Hall B, Level 2 (Orange County Convention Center) Authors: Esther Natalie Oliva1,...